levodopa - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19A"

Product details Supply Impact Dates Further Details
SINEMET 250/25 levodopa/carbidopa 250mg/25mg tablet bottle
AUST R: 171666
Active ingredients:
carbidopa monohydrate
levodopa

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800 818 553

From
23 Aug 2018
to
31 Dec 2019

Status:
Current

Patient impact:
Medium

Availability:
Emergency Supply Only

Reason:
Other

TGA Management Actions:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

SINEMET 100/25 levodopa/carbidopa 100mg/25mg tablet bottle
AUST R: 171665
Active ingredients:
carbidopa monohydrate
levodopa

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800 818 553

From
23 Aug 2018
to
31 Dec 2019

Status:
Current

Patient impact:
Medium

Availability:
Unavailable

Reason:
Other

TGA Management Actions:
18/01/19 The sponsor is closely controlling the supply. Alternative generic products may be available.

SINEMET CR levodopa/carbidopa 200mg/50mg modified release tablet bottle
AUST R: 171694
Active ingredients:
carbidopa monohydrate
levodopa

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800 818 553

From
15 Jan 2019
to
31 Dec 2019

Status:
Current

Patient impact:
Critical

Availability:
Emergency Supply Only

Reason:
Other

TGA Management Actions:
17/01/19 The sponsor is closely controlling the supply.